IL2 and laryngotracheoesophageal cleft: In one interesting study, an interleukin 2 (IL-2) liposome inhalation formulation was designed, fabricated, and tested, and the outcome of the study showed no evidence of toxicity, and it was found to be safe for LC patients [66].